Dianthus Therapeutics (DNTH) Interest Expenses (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Interest Expenses of $127.5 million for Q4 2025, up 63673.5% year-over-year from N/an in Q4 2024, and up 1.05% quarter-over-quarter from $126.2 million in Q3 2025.
Dianthus Therapeutics (DNTH) Interest Expenses (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Interest Expenses history runs 9 years deep, the most recent figure standing at $127.5 million for Q4 2025.
- In Q4 2025, Interest Expenses rose 63673.5% year-over-year to $127.5 million; the TTM figure through Dec 2025 stood at $127.5 million (up 63673.5% YoY), while the FY2025 annual figure was $127.5 million, down 29.77% from the prior year.
- Interest Expenses for Q4 2025 stood at $127.5 million, up from $126.2 million in the prior quarter.
- The five-year high for Interest Expenses was $127.5 million in Q4 2025, with the low at $5000.0 in Q2 2023.
- The 5-year median for Interest Expenses is $14.7 million (2025), against an average of $31.5 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses sank 99.99% in 2023, then jumped 855560.0% in 2024.
- Dianthus Therapeutics' Interest Expenses stood at $5.2 million in 2021, then soared by 700.35% to $41.6 million in 2022, then sank by 81.33% to $7.8 million in 2023, then tumbled by 97.42% to $200000.0 in 2024, then soared by 63673.5% to $127.5 million in 2025.
- Business Quant data shows DNTH's Interest Expenses at $127.5 million in Q4 2025, $126.2 million in Q3 2025, and $15.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 127.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127.55 Mn |
| Dec 31, 2025 | 127.55 Mn |
| Sep 30, 2025 | 126.22 Mn |
| Sep 30, 2025 | 126.22 Mn |
| Jun 30, 2025 | 15.47 Mn |
| Jun 30, 2025 | 15.47 Mn |
| Mar 31, 2025 | 14.01 Mn |
| Mar 31, 2025 | 14.01 Mn |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 49.03 Mn |
| Sep 30, 2024 | 49.03 Mn |
| Jun 30, 2024 | 42.78 Mn |
| Jun 30, 2024 | 42.78 Mn |
| Mar 31, 2024 | 51.07 Mn |
| Mar 31, 2024 | 51.07 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Sep 30, 2023 | 7.76 Mn |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |